Richard H Weiner

Address:

8615 Directors Row, Dallas, TX 75247

Phone:

2146385019

VIN:

KMHDB8AE8AU061381

Make:

HYUNDAI

Model:

ELANTRA TOURING

Year:

2010

Address:

8615 Directors Row, Dallas, TX 75247

Phone:

2146385019

VIN:

1GNFC13578R176895

Make:

CHEVROLET

Model:

TAHOE

Year:

2008

US Patent:

6505075, Jan 7, 2003

Filed:

May 22, 2000

Appl. No.:

09/577258

Inventors:

Richard L. Weiner - Dallas TX 75230

International Classification:

A61N 118

US Classification:

607 46

Abstract:

A method for treating pain by subcutaneous electrical stimulation of a peripheral nerve is disclosed. A lead is placed subcutaneously over a peripheral nerve that is causing pain. The peripheral nerve is electrically stimulated to cause paresthesia. The method encompasses subcutaneous placement of an electrical lead near any peripheral nerve causing pain and subsequent electrical stimulation of the nerve to cause paresthesia. In particular, a method for treating intractable occipital neuralgia using percutaneous peripheral nerve electrostimulation techniques is disclosed.

US Patent:

7300920, Nov 27, 2007

Filed:

Nov 14, 2003

Appl. No.:

10/714067

Inventors:

Richard I. Weiner - Muir Beach CA, US
Joseph A. Martial - Esneux, BE
Ingrid Struman - Faimes, BE
Robert Taylor - San Francisco CA, US
Frauke Bentzien - San Francisco CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61K 38/18
A61K 31/27
C07K 14/475
C07K 14/61

US Classification:

514 12, 530399, 530300

Abstract:

The current invention provides novel antiangiogenic peptides which correspond to about 133 consecutive amino acids of the N-terminal sequence of growth hormone.

US Patent:

8457757, Jun 4, 2013

Filed:

Nov 26, 2008

Appl. No.:

12/323854

Inventors:

Larry Cauller - Plano TX, US
Richard Weiner - Dallas TX, US

Assignee:

Micro Transponder, Inc. - Austin TX

International Classification:

A61N 1/36

US Classification:

607 61

Abstract:

A method and system for providing electrical stimulation to tissue includes implanting one or more battery-free microtransponders having spiral antennas into tissue. Energy is provided wirelessly to the plurality of microtransponders. Tissue is stimulated using the energy.

US Patent:

20020198572, Dec 26, 2002

Filed:

Jul 30, 2002

Appl. No.:

10/208146

Inventors:

Richard Weiner - Dallas TX, US

Assignee:

Medtronic, Inc. - Minneapolis MN

International Classification:

A61N001/18

US Classification:

607/046000

Abstract:

A method for treating pain by subcutaneous electrical stimulation of a peripheral nerve is disclosed. A lead is placed subcutaneously over a peripheral nerve that is causing pain. The peripheral nerve is electrically stimulated to cause paresthesia. The method encompasses subcutaneous placement of an electrical lead near any peripheral nerve causing pain and subsequent electrical stimulation of the nerve to cause paresthesia. In particular, a method for treating intractable occipital neuralgia using percutaneous peripheral nerve electrostimulation techniques is disclosed.

US Patent:

20030186382, Oct 2, 2003

Filed:

Mar 27, 2001

Appl. No.:

09/819094

Inventors:

Richard Weiner - Muir Beach CA, US
Joseph Martial - Modave, BE
Ingrid Struman - Boncelles, BE
Robert Taylor - San Francisco CA, US
Frauke Bentzien - San Francisco CA, US

International Classification:

A61K038/27
C12P021/02
C07H021/04
C12N005/06
C07K014/61

US Classification:

435/069400, 435/325000, 435/320100, 530/399000, 514/012000, 536/023500

Abstract:

The current invention concerns novel antiangiogenic peptides which correspond to about 10 to about 150 consecutive amino acids of N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin, and their use in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormalities of placental vascularization.

US Patent:

20060206166, Sep 14, 2006

Filed:

Mar 17, 2006

Appl. No.:

11/378094

Inventors:

Richard Weiner - Dallas TX, US

Assignee:

Medtronic, Inc. - Minneapolis MN

International Classification:

A61N 1/34

US Classification:

607046000

Abstract:

An apparatus for treating pain by electrical stimulation is disclosed. A lead is placed subcutaneously in the region of pain. The subcutaneous tissue is electrically stimulated to cause paresthesia. The method encompasses subcutaneous placement of an electrical lead near the region of pain and subsequent electrical stimulation of the tissue to cause paresthesia. In particular, an apparatus for treating intractable occipital neuralgia using percutaneous electrostimulation techniques is disclosed.

US Patent:

20080090750, Apr 17, 2008

Filed:

Oct 19, 2007

Appl. No.:

11/875308

Inventors:

Richard Weiner - Muir Beach CA, US
Joseph Martial - Modave, BE
Ingrid Struman - Boncelles, BE
Robert Taylor - San Francisco CA, US
Frauke Bentzien - San Francisco CA, US

Assignee:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA

International Classification:

A61K 38/00
A61P 43/00
C07K 16/00

US Classification:

514002000, 530300000

Abstract:

The current invention concerns novel antiangiogenic peptides which correspond to about 10 to about 150 consecutive amino acids of N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin, and their use in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormalities of placental vascularization.

US Patent:

20080096795, Apr 24, 2008

Filed:

Oct 19, 2007

Appl. No.:

11/875323

Inventors:

Richard Weiner - Muir Beach CA, US
Joseph Martial - Modave, BE
Ingrid Struman - Boncelles, BE
Robert Taylor - San Francisco CA, US
Frauke Bentzien - San Francisco CA, US

Assignee:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA

International Classification:

A61K 38/00
A61P 43/00
C07K 16/00

US Classification:

514002000, 530300000

Abstract:

The current invention concerns novel antiangiogenic peptides which correspond to about 10 to about 150 consecutive amino acids of N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin, and their use in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormalities of placental vascularization.